Patent: 4,530,901
✉ Email this page to a colleague
Summary for Patent: 4,530,901
Title: | Recombinant DNA molecules and their use in producing human interferon-like polypeptides |
Abstract: | Recombinant DNA molecules and hosts transformed with them which produce polypeptides displaying a biological or immunological activity of human interferon, the gene coding for these polypeptides and methods of making and using these molecules, hosts, genes and polypeptides. The recombinant DNA molecules are characterized by structural genes that code for a polypeptide displaying a biological or immulogical activity of human interferon. In appropriate hosts these molecules permit the production and identification of genes and polypeptides displaying a biological or immunological activity of human interferon and their use in antiviral and antitumor or anticancer agents. |
Inventor(s): | Weissmann; Charles (Zurich, CH) |
Assignee: | Biogen N.V. (Curacao, AN) |
Application Number: | 06/118,084 |
Patent Claims: | see list of patent claims |
Details for Patent 4,530,901
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Llc | INTRON A | interferon alfa-2b | For Injection | 103132 | June 04, 1986 | ⤷ Sign Up | 2002-07-23 |
Merck Sharp & Dohme Llc | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Sign Up | 2002-07-23 | |
Merck Sharp & Dohme Llc | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Sign Up | 2002-07-23 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 4,530,901
Country | Patent Number | Estimated Expiration |
---|---|---|
Austria | E9005 | ⤷ Sign Up |
Australia | 553400 | ⤷ Sign Up |
Australia | 6605781 | ⤷ Sign Up |
Bosnia and Herzegovina | 96096 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |